Actively Recruiting
Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group
Led by University Hospital, Bordeaux · Updated on 2025-11-25
160
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators want to evaluate ovarian reserve concerning patients with multiple sclerosis, compared to a control group of healthy women. This study will include women from 25 to 35 years old.
CONDITIONS
Official Title
Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged between 25 and 35 years
- Diagnosis of multiple sclerosis based on McDonald Criteria 2017
- French-speaking without comprehension disorders
- Affiliated with health insurance
- Willing to participate and provide signed informed consent
You will not qualify if you...
- History of ovarian surgery (cystectomy, annexectomy)
- Turner Syndrome
- Fragile X messenger ribonucleoprotein 1 (FMR1) premutation
- Endometriosis with risk of ovarian reserve alteration
- History of chemotherapy or pelvic radiotherapy
- Pregnant or breastfeeding women
- Persons deprived of liberty by judicial or administrative decision, minors, persons under legal protection, or unable to express consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de Bordeaux - service de neurologie
Bordeaux, France
Actively Recruiting
Research Team
V
Valérie BERNARD, MD
CONTACT
M
Mathilde DELOIRE, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here